3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Breast
2
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Conditions
Multiple Endocrine Neoplasia Type 1
3
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Obesity
1
Neuroendocrine Tumors
1
Motor Activity
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Interventions
Trastuzumab
2
vandetanib
1
tipifarnib
1
temsirolimus
1
entinostat
1
Vinorelbine
1
Standard of Care
1
Sirolimus
1
Microscopy, Electron
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
Fentanyl
1
Docetaxel
1
CYT-6091
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
Standard of Care
×
Endocrine
×
Clear all
NCT02957981
2023-09-13
GEM
Georgetown University
Phase NA
Completed
63 enrolled